UF Health Cancer Center

Gainesville, Florida 32610-3633

1 studies enrolling now · 20 studies all time

What they study most

ALS, Acute Myeloid Leukemia, Amyotrophic Lateral Sclerosis (ALS), Bladder Cancer, Chemotherapy, Colorectal Cancer Metastatic, Endometrial Cancer, Genotyping, Hematopoietic Neoplasm, Leukemia, Lung Cancer, Myelodysplastic Syndromes

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis — Recruiting now
• Safety Study of Oral Edaravone Administered in Subjects With ALS — Completed
• Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS) — Completed
• Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS — Stopped early
• Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR) — Completed
• Abemaciclib and Letrozole to Treat Endometrial Cancer — Running, not enrolling
• Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101) — Stopped early
• Women Helping Women - Lung Cancer Screening — Completed
• Genotype-guided Supportive Care in Symptom Treatment of Cancer Patients — Stopped early
• TAS-102 in Previously Treated Unresectable or Metastatic Squamous Cell Lung Carcinoma (UF-STO-LUNG-003) — Completed
• Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy — Stopped early
• Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure — Completed
• TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003) — Stopped early
• Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma — Completed
• Beat AML Core Study — Completed
• Sorafenib Plus Capecitabine (SorCape) in Previously Treated Metastatic Colorectal Cancer — Completed
• Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002) — Stopped early
• UF-BMT-HSCT-001: A Non-Interventional Study Evaluating Diet in HSCT Survivors — Completed
• Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer — Completed
• Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC. — Completed